Telegram
Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиEditas Medicine Мультипликаторы 2011-2024 | EDIT
Мультипликаторы по годам Editas Medicine
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-5.5 | -3.0 | -6.7 | -31.0 | -10.0 | -9.1 | -13.2 | -5.7 | - | - | - | - | - |
P/S |
10.8 | 33.8 | 50.4 | 39.6 | 65.3 | 31.4 | 115.3 | 90.9 | - | - | - | - | - |
EPS |
-2.0 | -3.2 | -2.9 | -2.0 | -2.7 | -2.3 | -3.0 | -3.0 | -28.6 | -12.5 | - | - | - |
EV (Enterprise Value) |
871 млн | 677 млн | 1.2 млрд | 3.63 млрд | 1.35 млрд | 1.05 млрд | 1.6 млрд | 459 млн | 89.3 млн | 27.5 млн | 4.24 млн | - | - |
EBITDA per Share |
-2.15 | -3.2 | -2.78 | -2.23 | -2.76 | -2.35 | -2.91 | -2.98 | - | - | - | - | - |
EV/EBITDA |
-6.4 | -28.1 | -8.0 | -7.9 | -12.3 | -3.9 | - | - | - | - | - | ||
PEG |
-5.05 | -0.8 | -23.28 | -1.26 | 0.67 | -0.42 | -9.93 | 0.12 | - | - | - | - | - |
P/B |
2.4 | 1.8 | 2.3 | 9.1 | 5.1 | 4.2 | 7.6 | 4.1 | - | - | - | - | - |
P/CF |
-6.4 | -3.8 | -7.9 | -20.0 | -28.6 | -19.9 | -137.9 | -10.3 | - | - | - | - | - |
ROE % |
-43.89 | -61.12 | -34.77 | -29.47 | -50.96 | -46.56 | -57.83 | -72.23 | - | - | - | - | - |
ROA % |
-30.70 | -42.86 | -28.41 | -20.25 | -26.28 | -26.16 | -32.24 | -42.42 | - | - | - | - | - |
ROCE % |
-48.46 | -62.65 | -34.89 | -34.26 | -31.39 | -29.58 | -35.64 | -49.56 | - | - | - | - | - |
Current Ratio |
3.3 | 3.3 | 5.5 | 3.2 | 7.7 | 10.4 | 9.1 | 5.7 | - | - | - | - | - |
DSO |
35.8 | 50.1 | 45.1 | 13.0 | 7.4 | 0.3 | 18.1 | 5.3 | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
35.8 | 50.1 | 45.1 | 13.0 | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
35.8 | 50.1 | 45.1 | 13.0 | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Editas Medicine
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.55 | -0.56 | -0.71 | - | -0.81 | -0.78 | -0.74 | - | -0.57 | -0.81 | -0.86 | -1 | 0.13 | -0.43 | -0.69 | - | -0.66 | -0.69 | -0.6 | -0.52 | -0.32 | -0.82 | -0.67 | - | -0.64 | -0.65 | -0.85 | - | -0.59 | -0.54 | -0.8 | - | -2.57 | -21.45 | -2.75 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | -0.72 | - | -0.77 | -0.79 | -0.72 | - | -0.52 | -0.82 | -0.84 | - | 0.19 | -0.54 | -0.84 | - | -0.65 | -0.7 | -0.63 | -0.54 | -0.29 | -0.81 | -0.67 | - | -0.6 | -0.61 | -0.82 | - | -0.58 | -0.53 | -0.79 | - | -2.41 | -4.59 | -2.59 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-51.45 | -52.39 | -53.80 | -34.77 | -41.43 | -34.66 | -32.18 | -24.56 | -40.44 | -31.79 | -28.77 | -29.47 | -27.98 | -42.52 | -49.40 | -50.96 | -47.18 | -41.08 | -44.60 | -46.56 | -53.34 | -59.67 | -55.98 | -57.83 | -69.69 | -72.52 | -73.96 | -72.20 | -27.75 | -3.22 | 68.16 | 87.71 | 72.51 | 63.60 | 6.37 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-37.41 | -38.99 | -39.66 | -26.71 | -32.16 | -19.01 | -26.32 | -20.03 | -30.95 | -24.13 | -20.94 | -20.25 | -16.76 | -24.60 | -27.12 | -26.28 | -24.82 | -21.97 | -24.54 | -26.16 | -29.89 | -33.39 | -31.26 | -32.24 | -39.72 | -41.77 | -42.99 | -42.40 | -33.68 | -29.47 | -53.01 | -48.81 | -40.35 | -35.39 | -3.54 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-54.86 | -54.82 | -55.44 | -35.42 | -42.11 | -34.93 | -32.31 | -24.64 | -22.35 | -13.38 | -12.31 | -17.52 | -30.70 | -46.17 | -51.79 | -38.68 | -49.79 | -43.50 | -46.71 | -48.16 | -49.89 | -55.87 | -51.62 | -40.12 | -55.85 | -58.72 | -60.43 | -43.24 | -34.36 | -9.75 | 17.02 | 27.60 | 27.60 | 18.72 | 6.21 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
3.5 | 3.8 | 3.2 | 3.4 | 4.6 | - | 5.7 | 5.5 | 5.5 | 5.3 | 5.5 | 3.2 | 3.2 | 3.2 | 3.2 | 2.1 | 2.1 | 2.1 | 2.1 | 2.3 | 2.3 | 2.3 | 2.3 | 2.3 | 2.3 | 2.3 | 2.3 | 2.4 | 2.4 | 2.4 | 2.4 | 4.6 | 4.6 | 4.6 | 4.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
40.3 | 40.0 | 24.9 | - | 130.4 | 9.8 | 11.0 | - | 4.3 | 120.7 | 47.2 | 48.3 | 8.8 | 51.3 | 51.5 | 3.1 | 9.9 | 16.4 | 9.9 | 0.5 | 0.2 | 0.4 | 8.2 | 16.9 | 9.9 | 20.0 | 51.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
40.3 | 40.0 | 24.9 | - | 130.4 | 9.8 | 11.0 | - | 4.3 | 120.7 | 47.2 | 48.3 | 8.8 | 51.3 | 51.5 | 3.1 | 9.9 | 16.4 | 9.9 | 0.5 | 0.2 | 0.4 | 8.2 | 16.9 | 9.9 | 20.0 | 51.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
40.3 | 40.0 | 24.9 | - | 130.4 | 9.8 | 11.0 | - | 4.3 | 120.7 | 47.2 | 48.3 | 8.8 | 51.3 | 51.5 | 3.1 | 9.9 | 16.4 | 9.9 | 0.5 | 0.2 | 0.4 | 8.2 | 16.9 | 9.9 | 20.0 | 51.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD